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OBJECTIVES The aim of this study was to assess the diagnosis of myocarditis in patients presenting with
acute myocardial infarction (MI) and normal coronary angiograms.
BACKGROUND Most often in these patients, the etiologic diagnosis remains unclear once they are found to
have normal coronary arteries. The diagnosis of myocarditis mimicking MI is clinically
relevant, because numerous arguments suggest a relation between myocarditis and dilated
cardiomyopathy. Myocardial indium-111 (111In)-antimyosin antibody (AMA)/rest thallium-
201 (201Tl) imaging allows noninvasive detection of myocarditis.
METHODS Forty-five patients admitted to three intensive care units for suspicion of acute MI, with
normal coronary angiograms, were investigated. Indium-111–AMA planar images and then
a dual-isotope rest AMA/201Tl tomographic study were performed. Six-month echocardio-
graphic follow-up was obtained in 80% of the patients with initial left ventricular (LV) wall
motion abnormalities.
RESULTS In eight patients, AMA and 201Tl scintigraphy were negative. In two patients, a matched
201Tl defect and focal AMA uptake suggested acute MI (due to prolonged vasospasm or
spontaneously reperfused coronary occlusion). In 17 patients, diffuse AMA uptake over the
whole LV suggested diffuse myocarditis. In 18 patients, focal AMA uptake with a normal
201Tl scan suggested diffuse but heterogeneous, or focal myocarditis. Complete functional
recovery was observed in 81% of the patients with a pattern of myocarditis.
CONCLUSIONS Among 45 patients presenting with acute MI and normal coronary angiograms, 38% had
diffuse myocarditis and 40% had a scintigraphic pattern of heterogeneous or focal myocarditis.
Short-term follow-up showed complete LV functional recovery in 81% of these patients.
(J Am Coll Cardiol 2001;37:786–92) © 2001 by the American College of Cardiology
Currently, much attention is paid to the diagnosis and
treatment of myocarditis, because clinical and experimental
arguments suggest a relation between infectious cardiac
disease and dilated cardiomyopathy (1–5). Deleterious im-
mune phenomena identical to those found in idiopathic
dilated cardiomyopathy (IDC) persist for many weeks after
the virus has disappeared in myocarditis. The long-term
outcome of patients with myocarditis may be as poor as that
in IDC (6,7). Very recent studies focused on clinical or
biologic (anticardiac autoantibodies) prognostic factors
(7,8).
Clinically, myocarditis can mimic myocardial infarction
(MI) (9–14), and so it is suspected in patients with clinical
and electrocardiographic (ECG) evidence of acute coronary
syndrome, and having normal coronary angiograms (;3%
of patients with presentation of MI) (15,16). However, the
prevalence of myocarditis in these patients is unknown. In
most cases, MI secondary to coronary vasospasm or spon-
taneously reperfused coronary occlusion is suggested, but no
definitive diagnosis is sought when the patient is found to
have normal coronary arteries. Endomyocardial biopsy is
rarely performed because of its poor risk/benefit ratio, due to
low sensitivity (17–19). Indium-111 (111In)-antimyosin an-
tibody (AMA) scintigraphy, which allows specific detection
of myocytic necrosis, has been widely reported as a useful
tool to diagnose myocarditis, particularly those cases mim-
icking acute MI (11,20–22).
In this study, AMA scintigraphy coupled with rest
thallium-201 (201Tl) myocardial imaging was prospectively
performed in 45 patients presenting with acute MI and
normal coronary angiograms.
METHODS
Patients. Forty-five patients were prospectively included in
this study during a 31-month period. They were referred by
the intensive care units of three cardiology departments.
The inclusion criteria were recent onset of acute, prolonged
(.30 min) chest pain, ischemic ECG abnormalities during
the acute phase, serum elevation of creatine kinase (CK) or
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troponin I, or both, and normal coronary angiograms (no
significant coronary stenosis, no visible coronary thrombus
or unstable plaque, no vasospasm). Patients with typical
presentation of myopericarditis were excluded on the basis
of young age, no cardiac risk factors but recent acute febrile
illness, chest pain characteristic of pericardial involvement
or pericardial friction rub, diffuse ST segment changes but
no Q waves on the ECG and pericardial fluid but no
segmental wall motion abnormalities on the echocardio-
gram obtained within 24 h after the onset of chest pain.
During the study period, 1,280 patients were admitted for
MI in the three study centers; 4% of them had normal
coronary angiograms.
The characteristics of the study group on hospital admis-
sion are described in Table 1. Eight patients had more than
one coronary risk factor, and 23 had one risk factor. Sixteen
patients had a fever. Two patients had clinical left ventric-
ular (LV) failure. The ECG findings included Q waves in
12 patients, ST segment elevation in 29 and ST segment
depression in 4. The biologic findings included elevated
peak serum CK levels in 41 patients, elevated CK-MB
fraction titer alone in 1 and elevated troponin I level alone
in 3.
Fifteen patients had angiography of the coronary arteries
within 6 h of hospital admission, and three patients had
thrombolytic therapy. The other patients were not consid-
ered for thrombolysis or coronary angioplasty on hospital
admission because of pregnancy (n 5 1), delayed appearance
of Q waves and segmental wall motion abnormalities
leading to re-evaluation of the initial diagnosis (from
pericarditis to MI or myocarditis, n 5 2) or late admission
(.6 h after the beginning of chest pain, n 5 24). They all
received anti-ischemic therapy.
Coronary angiography. All patients underwent coronary
angiography for suspicion of coronary artery disease respon-
sible for acute MI. The scans were normal in all patients. A
vasoconstrictor ergonovine test was performed in three
patients and was always negative. Right ventricular endo-
myocardial biopsy was performed in two patients.
Two-dimensional echocardiography was also performed
in all patients within 24 h of hospital admission (directly on
admission in 31), according to the recommendations of the
American Society of Echocardiography.
Indium-111–AMA/201Tl scintigraphy. Coupled 111In-
AMA and rest 201Tl scintigraphy was performed in all
patients at a mean time of 11.1 6 6.4 days after the onset of
chest pain. The imaging procedure was the same as previ-
ously described (23,24). First, 74 Mbq of 111In-AMA was
injected intravenously (whole-body radiation dose: 19.2
mSv). Forty-eight hours later, planar thoracic images (an-
terior and oblique anterior views) were acquired, with a 20%
window centered on the 173- and 247-keV photopeaks of
111In and a preset time of 10 min. Then, 111 MBq of 201Tl
was injected, and dual-isotope single-photon emission com-
puted tomography (SPECT) was performed 30 to 60 min
later, with 20% windows fitted on 74-, 173- and 247-keV
photopeaks. The two data sets (201Tl-SPECT and 111In-
SPECT) were simultaneously, identically and automatically
processed, centered and reoriented along the three axes with
the help of 201Tl acquisition as a landmark. Corresponding
slices for each SPECT acquisition were displayed simulta-
neously and could be superimposed for better 111In-AMA
uptake localization.
Data analysis. On angiography and echocardiography, the
extent of wall motion abnormalities was semiquantified as
the number of hypokinetic or dyskinetic segments, after LV
segmentation in nine segments (apical and basal parts of the
anterior, inferior, lateral and septal walls, plus the apex).
The planar and tomographic scintigrams were scored in
blinded manner by two investigators from the Department
of Nuclear Medicine. A consensus reading was made in case
of disagreement. Indium-111–AMA scintigraphy was
scored as normal or abnormal on planar images, both
visually and after calculating a heart to lung ratio (HLR), by
using two regions of interest—one in the cardiac area and
the other in the right lung. Left ventricular AMA uptake
was considered significant when the HLR was .1.8. This
Abbreviations and Acronyms
AMA 5 antimyosin antibody
CK 5 creatine kinase
HLR 5 heart to lung ratio
IDC 5 idiopathic dilated cardiopathy
111In 5 indium-111
LV 5 left ventricle or left ventricular
LVEF 5 left ventricular ejection fraction
MI 5 myocardial infarction
SPECT5 single photon emission computed tomography
201Tl 5 thallium-201
Table 1. Patient Characteristics on Hospital Admission
Study Group
(n 5 45)
Age (yrs) 43 6 18
Gender ratio (M/F) 29/16
Chest pain 45 (100%)
Cardiac risk factors 31 (70%)
Recent history of viral illness 22 (49%)
ECG changes
ST segment elevation 29 (64%)
ST segment depression 4 (9%)
Pathologic Q-waves 12 (27%)
Mirror ST segment changes 17 (28%)
Peak serum CK level (UI/liter) 595 6 469
CRP .10 mg/liter 30 (67%)
Normal coronary arteries 45 (100%)
Thrombolytic therapy 3 (7%)
Delay between admission and angiography
,6 h 15 (33%)
,24 h 28 (62%)
,72 h 35 (78%)
Data are presented as the mean value 6 SD or number (%) of patients.
CK 5 creatinine kinase; CRP 5 C-reactive protein; ECG 5 electrocardiographic;
F 5 female; M 5 male.
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threshold value was previously determined on the basis of
the mean HLR value 6 2 SD in six healthy volunteers (25).
Significant AMA uptake was scored as diffuse or regional on
the basis of tomographic data, and its extent was quantified
after LV segmentation identical to that used for quantifi-
cation of wall motion abnormalities.
The etiologic interpretation was done as follows: 1)
diffuse myocarditis in case of diffuse AMA uptake through-
out the whole LV myocardium (no matter what the 201Tl
uptake was); 2) MI due to prolonged vasospasm or sponta-
neously reperfused coronary occlusion in case of segmental
AMA uptake and matched 201Tl defect; and 3) focal
myocarditis in case of a mismatched pattern associating
focal AMA uptake with normal 201Tl uptake.
Follow-up. Repeated clinical and ECG studies were per-
formed during follow-up (6 6 8 months) in 32 (71%) of 45
patients. Echocardiography was also repeated in 27 (77%) of
35 patients with initial LV wall motion abnormalities.
Scintigraphic follow-up with delayed AMA scans was done
2 to 16 months (mean 5 6 5) after the first evaluation in
seven patients with significant myocardial AMA uptake on
the initial scan.
Statistical analysis. Descriptive continuous variables were
expressed as the mean value 6 SD. A comparison of mean
values was performed using the Student unpaired t test and
chi-square analysis. Significant differences were considered
at p , 0.05.
RESULTS
Initial wall motion studies. Normal global and segmental
LV function was found in 10 patients (22%), global hypo-
kinesia without regional abnormalities in seven patients
(16%; mean LV ejection fraction [LVEF] 40.8 6 11.5%)
and regional wall motion abnormalities in 28 patients (62%;
decrease in LVEF [mean value 49.5 6 3.9%], n 5 4). None
of the patients had LV dilation (mean end-diastolic LV
diameter 50.5 6 4.0 mm). Mild pericardial effusion was
found in seven patients with localized ischemic ECG
abnormalities or pathologic Q waves (n 5 1).
Scintigraphic results. Coupled 111In-AMA and rest 201Tl
scintigraphy was performed at a mean time of 11.1 6 6.4
days after the onset of angina. The intraobserver and
interobserver reproducibilities of the image reading were
90% and 85%, respectively. The mean difference in HLR
values between the two observers was 5.12%. Eight patients
(18%) had negative AMA scintigraphy (HLR 1.53 6 0.30
[range 1.40 to 1.70]), and the 201Tl scan was normal in all
eight patients. Thirty-seven patients (82%) showed signifi-
cant LV AMA uptake (HLR 2.14 6 0.33 [range 1.82 to
3.2]).
Seventeen patients (38%) had diffuse AMA uptake in-
volving the whole LV myocardium (and also the right
ventricle in two patients), suggesting diffuse myocarditis
without a 201Tl defect in 14 patients (Fig. 1) and with a
201Tl defect involving four and six segments in two patients.
In eight of these patients, AMA uptake was more pro-
nounced in one particular region. Eighteen patients (40%)
showed focal AMA uptake without a 201Tl defect (Fig. 2).
The territories affected by AMA uptake were systematized
in 11 patients (apical in 7, lateral in 1, inferior in 1 and
inferolateral in 2) and not systematized, involving the apex
and part of or all of the lateral wall, in the other seven
Figure 1. Scintigraphic pattern of diffuse myocarditis. The AMA planar
images (A, HLR 2.1) and 111In-AMA/201Tl SPECT data (B, correspond-
ing 111In-AMA and 201Tl slices) show diffuse AMA uptake throughout
the whole LV myocardium, as well as normal 201Tl uptake. ANT 5
anterior; LAO 5 left anterior oblique.
Figure 2. Scintigraphic pattern of focal myocarditis. The AMA planar
images (A, HLR 2.4) and 111In-AMA/201Tl SPECT (B, corresponding
AMA and 201Tl slices) show focal AMA uptake on the apex and the lateral
LV wall, as well as a normal 201Tl scan. In this patient, coronary
angiography and intracoronary contrast echocardiography performed dur-
ing intense chest pain were normal, except for hypokinesia of the inferior
and lateral walls. The chest pain persisted 6 h despite anti-ischemic
therapy. Three months later, the ECG was normalized, and echocardiog-
raphy showed mild global hypokinesia (LVEF 50%) without segmental
wall motion abnormalities. ANT 5 anterior; LAO 5 left anterior oblique.
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patients. The mean extent of AMA uptake was 2.4 6 0.7
segments (range 1 to 5). Two patients (4%) showed
matched focal AMA uptake (HLR 1.84 and 2.4) and a
201Tl defect in the inferior wall (extent of three and four
segments), a pattern highly suggestive of acute inferior MI.
The results of ECG changes and LV wall motion studies
according to scintigraphic patterns are reported in Table 2.
Right ventricular endomyocardial biopsy performed in
two patients with focal AMA uptake (apical/inferior) and a
normal 201Tl scan revealed lymphocytic myocarditis accord-
ing to the Dallas criteria (26).
Follow-up. During the hospital period, chest pain per-
sisted despite anti-ischemic therapy in most patients (.2 h
in 68%, mean duration 5.7 6 6.4 h). The mean chest pain
duration was lower in patients with a negative AMA scan
versus a positive scan (1.5 6 1.3 h vs. 10.5 6 8 h, p 5 0.03).
In the 32 patients without pathologic Q waves on hospital
admission, the ECG abnormalities did not evolve into a
pattern of typical acute MI. During follow-up (Table 3),
echocardiography revealed persistent wall motion abnor-
malities in 4 (15%) of 27 patients (global LV hypokinesia in
one patient [LVEF 50%], only segmental abnormalities in
three patients). The three patients with initial ST segment
depression who were followed showed ECG and echocar-
diographic normalization. In six of seven patients with
scintigraphic follow-up, the delayed AMA scan became
negative (HLR 1.60 6 0.25), with still normal 201Tl uptake
in five patients and a larger inferior 201Tl defect in one
patient (with an initial pattern suggestive of acute MI). In
one patient, the HLR decreased but was not normalized
(from 2.5 to 1.9) after three months, and the 201Tl scan was
still normal.
DISCUSSION
This study reports on 45 patients with initial clinical
presentation of acute MI, normal coronary angiograms and
a pattern of 111In-AMA/201Tl uptake highly suggestive of
myocarditis in 35 of them.
Which diagnosis in patients presenting with acute MI
and normal coronary angiograms? The diagnosis of myo-
carditis is particularly misleading, although such a clinical
presentation mimicking acute MI has been widely reported
(9–14,27,28). Furthermore, there is a lack of reliable tools for
the positive diagnosis of myocarditis, which is based on
histologic Dallas criteria (26). Endomyocardial biopsy is inva-
sive, induces significant cardiovascular risk and is insensitive
because of sampling error related to the patchy distribution of
the disease, as well as high interobserver variability on histo-
logic analysis: 10% to 22% sensitivity according to some
investigators (17–20,29,30). In 34 patients presenting with MI
and normal coronary angiograms, Dec et al. (10) reported a
30% rate of histologically proven myocarditis; this prevalence is
probably underestimated for the same reasons. Immunohisto-
logic techniques seem more sensitive (31). However, this is still
an invasive technique that is not routinely used, especially
during the acute phase of MI. The other main etiologic
hypothesis in these patients is acute MI, which is difficult to
diagnose in the absence of visible coronary spasm or thrombus
on the angiogram. In practice, after coronary angiography has
















Q waves 2 7 3 (3*) 0
ST segment elevation 4 9 14 (10*) 2 (2*)
ST segment depression 2 1 1 (1*) 0
Wall motion studies
Normal LV function 2 2 5 1
Global LV hypokinesia (no regional abnormalities) 1 6 0
Regional wall motion abnormalities 5 9 13 1
Decreased LVEF 1 7 4 0
*Number of patients in whom the location of AMA uptake corresponded with that of ECG abnormalities.
AMA 5 antimyosin antibody; ECG 5 electrocardiographic; LV 5 left ventricular; LVEF 5 left ventricular ejection fraction; Tl 5 thallium.















ECG normalization 4/6 (75%) 8/11 (73%) 9/13 (69%) 2/2 (100%)
Echocardiographic normalization 5/5 (100%), 1* 8/10 (80%), 5* 9/11 (82%), 2* 1/1 (100%), 1*
Scintigraphic normalization 2/3 (66.6%) 4/4 (100%)
*Number of patients with an abnormal initial echocardiogram who were lost to follow-up.
Abbreviations as in Table 2.
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been performed, a reliable noninvasive tool for assessing
myocardial damage is required.
Diagnostic role of AMA scintigraphy. Indium-111–
AMA scintigraphy, using antibodies specific for damaged
myocytes, allows in vivo detection of recent myocytic
necrosis, no matter what the cause and mechanism of cell
damage (32). Although this cannot prove myocardial in-
flammation, it was shown to be a reliable noninvasive
technique for the diagnosis of myocarditis by demonstrating
myocytic damage induced by the inflammatory process.
Compared with histologic analysis alone, it has 80% to
100% sensitivity and an apparent lack of specificity (;60%)
(20,21). Compared with coupled histologic and immuno-
histologic data, Ku¨hl et al. (31) reported a sensitivity of 66%
and a good specificity of 71%. Indium-111–AMA scintig-
raphy also allows detection of MI (.90% sensitivity) (33).
Besides myocarditis and MI, the other main causes of
positive AMA scintigraphy are toxic cardiac injury and
IDC, which do not concern our study patients (34–36). In
our study, AMA scintigraphy detected myocardial damage
in 82% of patients.
Indium-111–AMA/201Tl scintigraphic pattern of MI.
Acute MI, whatever its mechanism (coronary occlusion
with spontaneous reperfusion or prolonged coronary
spasm), implies a no-flow phenomenon in a coronary artery.
Therefore, the resulting myocardial necrosis is confluent,
occurs in the area depending on the infarct-related artery
and induces intense segmental AMA uptake and a matched
perfusion and metabolism defect, as previously reported
(37,38). None of these mechanisms can explain diffuse LV
(or right ventricular) myocardial AMA uptake (38% of our
patients) or focal and poorly systematized AMA uptake
without a matched 201Tl defect (40% of our patients). It is
of little clinical value that no spastic episode occurred in any
of the patients, neither before the time of the study nor
during the follow-up period. Also, no coronary thrombus or
spasm was observed in six patients who had coronary
angiography during chest pain; one of them (Fig. 2) also had
intracoronary contrast echocardiography, which did not
show evidence of any flux abnormality of the microvascula-
ture.
A normal 201Tl scan can be observed after rapidly
reperfused MI (20% of patients in a previous study done at
our institution) (39). However, in such cases, myocytic
necrosis is probably not detectable with AMA scintigraphy
11 6 6 days after the acute episode, for two reasons: 1) these
cases probably correspond with limited nontransmural MI
with mild myocytic necrosis, because, according to Khaw et
al. (40), there is an inverse correlation between the intensity
of AMA uptake and that of early and late 201Tl uptake; and
2) 11 6 6 days after this transient and mild necrotic process,
AMA uptake is probably not significant, because part of the
necrosed myocytes has been removed by macrophages. In
our experience, in patients with a recent acute MI and
angioplasty during the acute phase, only two scintigraphic
patterns were observed: a 201Tl defect with matched focal
AMA uptake or a normal 201Tl scan with a negative AMA
scan. Finally, in this study, a scintigraphic pattern typical of
acute MI was observed in only two patients.
Indium-111–AMA/201Tl scintigraphic pattern of myo-
carditis. Diffuse myocardial AMA uptake is typical of
diffuse myocarditis (10,20–22). Thallium-201 scintigraphy
shows no defect in most of these cases because of the patchy
distribution of the necrosed myocytes, which coexist with
viable cells (23,24,41). Histologically proven myocarditis
also has been previously reported in patients with focal
AMA uptake but no 201Tl defect, as found in two patients
of our series (41). Other investigators have not mentioned
this scintigraphic pattern in myocarditis. However, their
study group and methodology were different from ours, with
a higher proportion of patients with decreased LVEF
(associated with diffuse AMA uptake [Table 2]) and no
tomographic AMA acquisitions, which are needed to pre-
cisely determine the topography of AMA uptake (10,22).
The main hypothesis for this scintigraphic pattern is that we
detect only part of a diffuse but heterogeneous process of
myocardial injury at the site where it is intense and/or recent
enough to be detected. Thus, 50% of our patients with
diffuse AMA uptake had markedly increased uptake in one
particular region corresponding to the ECG and regional
wall motion abnormalities; two of these patients had a 201Tl
defect. Focal confluent necrosis in diffuse myocarditis has
previously been reported in a study with postmortem his-
tologic examination (42). The hypothesis of strictly focal
myocarditis has also been suggested. Experimental viral
infections and meticulous attention at necropsy and biopsy
frequently confirm myocarditis to be a focal or multifocal
myocardial lesion (27,28,43–45). It is worth noting that
initial and residual segmental wall motion abnormalities, as
well as the presence of coronary artery disease, do not
exclude the diagnosis of myocarditis (9–14,27,28,42–44).
In our study, focal AMA uptake was preferentially seen in
the lateral and apical LV walls, suggesting that the necrotic
process is more intense in these segments. In a previous
autopsy study, gross myocardial lesions were more often
seen in the LV free wall than in the septal wall (46). In a
study using percutaneous cardioscopy, the authors per-
formed biopsy in the three wall segments that did not
exhibit normal brown color, usually the apical, lateral and
inferobasal segments in each patient; this may suggest that
these locations were preferentially involved by the process
(47). Methodologic reasons may explain a lack of detection
of focal inferior AMA uptake—that is, because of high liver
AMA activity, which is just close to the inferior wall of the
LV. However, they cannot clearly explain an eventual lack
of detection in the anterior or septal walls or false positive
images in the apex. As an indirect confirmation of apical
involvement in our cases of pure apical or apicolateral AMA
uptake (n 5 14), it is worth noting that wall motion
abnormalities, when present (10 of 14 patients), always
concerned the apex.
790 Sarda et al. JACC Vol. 37, No. 3, 2001
Myocarditis Mimicking MI March 1, 2001:786–92
Patients with negative scintigraphy. Scintigraphy was
performed in the same delay in patients with AMA-
negative and AMA-positive scans (9.5 6 5.2 vs. 11.4 6 6.9
days; p 5 NS).
The initial characteristics and follow-up data of patients
with AMA-negative scans suggest that, like the others, they
had experienced an acute episode of myocardial injury, but
less intense and too mild to be detected by 111In-AMA/
201Tl scintigraphy. It could be mild or limited myocarditis
(reported sensitivity of AMA scintigraphy is 66% to 100%)
or transient troncular ischemia or occlusion leading to a
limited nontransmural myocardial necrosis.
Prognosis of patients. Short-term follow-up of patients
with a pattern of myocarditis showed a favorable course of
the disease in the majority, but not all, of them; there was
complete LV functional recovery in 81% and scintigraphic
normalization in six of seven patients. Given some data
previously reported in patients with MI and normal coro-
nary angiograms, and because numerous arguments suggest
a relation between myocarditis and IDC, more attention
should be paid to the long-term follow-up of these patients
(1–5,48). It is worth noting that in one of our patients, the
control scintiscan showed persistent AMA uptake while
echocardiography was normalized at the same time; this
suggests that a milder but chronic process of myocardial
damage persisted even though the acute episode had been
resolved.
Study limitations. Endomyocardial biopsy was not per-
formed in most cases because the risk was considered too
high in these patients who potentially had acute MI. We did
not perform systematic ergonovine testing because of the
absence of legal authorization at the time of the study.
Conclusions. In this prospective series of 45 patients
presenting with MI and normal coronary angiograms, the
clinical, ECG, scintigraphic and follow-up data were con-
clusive for diffuse myocarditis in 17 patients (38%) and
suggested diffuse heterogeneous or focal myocarditis in 18
patients (40%). Short-term follow-up showed complete LV
functional recovery in 81% of these patients. Because many
arguments suggest a relation between myocarditis and IDC
(especially identical immune phenomena), these findings
prompt us to pay more attention to the anticardiac autoim-
mune status and to long-term follow-up of these patients
(1–5,8).
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